EP 1429732 A4 20050126 - A CORE FORMULATION
Title (en)
A CORE FORMULATION
Title (de)
KERNFORMULIERUNG
Title (fr)
FORMULATION DE NOYAU
Publication
Application
Priority
US 0121676 W 20010710
Abstract (en)
[origin: WO03005991A1] This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
IPC 1-7
IPC 8 full level
A61K 9/24 (2006.01); A61K 9/28 (2006.01); A61K 31/155 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP)
A61K 9/209 (2013.01); A61K 31/155 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2017.12)
Citation (search report)
- [E] WO 03005995 A1 20030123 - AEROPHARM TECHNOLOGY INC [US]
- [E] WO 0182875 A2 20011108 - AEROPHARM TECHNOLOGY INC [US]
- [XY] WO 0135940 A2 20010525 - SMITHKLINE BEECHAM PLC [GB], et al
- [XYD] US 6011049 A 20000104 - WHITCOMB RANDALL WAYNE [US]
- [XY] US 6166043 A 20001226 - IKEDA HITOSHI [JP], et al
- [Y] WO 0137808 A1 20010531 - LIPOCINE INC [US]
- [Y] DEASY P B ET AL: "COMBINED DIPYRIDAMOLE AND ASPIRIN PELLET FORMULATION FOR IMPROVED ORAL DRUG DELIVERY. PART 1: DEVELOPMENT PHARMACEUTICS", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS INC. LONDON, GB, vol. 13, no. 4, 1 July 1996 (1996-07-01), pages 385 - 394, XP000589902, ISSN: 0265-2048
- See references of WO 03005991A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03005991 A1 20030123; AU 2001273310 B2 20041007; CA 2453784 A1 20030123; EP 1429732 A1 20040623; EP 1429732 A4 20050126; JP 2004536841 A 20041209; MX PA04000176 A 20041027
DOCDB simple family (application)
US 0121676 W 20010710; AU 2001273310 A 20010710; CA 2453784 A 20010710; EP 01952575 A 20010710; JP 2003511799 A 20010710; MX PA04000176 A 20010710